Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03509012
Title Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid Tumors (CLOVER)
Acronym CLOVER
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Age Groups: senior | adult
Covered Countries USA | ESP

No variant requirements are available.